Shares in Bayer were up 6.3% in premarket trade at broker Lang & Schwarz on Friday, driven by a report on a possible out of court settlement of a U.S. jury trial over allegations that its weed killer Roundup causes cancer. Reuters Health News

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Time limit is exhausted. Please reload CAPTCHA.